Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25689
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTeh, Jiasian-
dc.contributor.authorDuncan, Catriona-
dc.contributor.authorQu, Liang G-
dc.contributor.authorGuerra, Glen-
dc.contributor.authorNarasimhan, Vignesh-
dc.contributor.authorPham, Toan-
dc.contributor.authorLawrentschuk, Nathan-
dc.date2020-12-
dc.date.accessioned2021-01-26T22:55:56Z-
dc.date.available2021-01-26T22:55:56Z-
dc.date.issued2020-12-
dc.identifier.citationTranslational Andrology and Urology 2020; 9(6): 3210-3218en
dc.identifier.issn2223-4691
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/25689-
dc.description.abstractPenile cancer is an uncommon disease associated with significant psychological and physical morbidity. Penile cancer has an expectable pattern of spread in a stepwise fashion, from inguinal to pelvic lymph nodes (PLN) then distant spread. Patients with penile cancer have variable survival, with patients with a low burden of nodal metastatic disease having lasting survival with surgical management, however patients with a large amount of locoregional metastatic disease having a worse prognosis. The current management options for patients with metastatic lymph node disease in penile cancer aims to reduce the morbidity associated with radical inguinal lymph node (ILN) surgery with appropriate risk stratification to optimise oncological control of the disease. This article describes current challenges in managing the inguinal region in patients with penile squamous cell carcinoma (SCC).en
dc.language.isoeng
dc.subjectPenile canceren
dc.subjectinguinal lymph node metastasis (ILN metastasis)en
dc.subjectsurgical oncologyen
dc.titleInguinal lymph node dissection for penile cancer: a contemporary review.en
dc.typeJournal Articleen
dc.identifier.journaltitleTranslational Andrology and Urologyen
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen
dc.identifier.affiliationYoung Urology Researchers Organisation (YURO), Melbourne, Victoria, Australiaen
dc.identifier.affiliationSurgery (University of Melbourne)en
dc.identifier.affiliationDivision of Cancer Surgery, Peter MacCallum Centre, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDivision of Cancer Research, Peter MacCallum Centre, Melbourne, Victoria, Australiaen
dc.identifier.affiliationSir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.doi10.21037/tau.2019.08.37en
dc.type.contentTexten
dc.identifier.pubmedid33457292
local.name.researcherQu, Liang G
item.languageiso639-1en-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptSurgery (University of Melbourne)-
crisitem.author.deptUrology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

52
checked on Nov 16, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.